Marshall Wace, LLP Acrivon Therapeutics, Inc. Transaction History
Marshall Wace, LLP
- $63.3 Billion
- Q1 2024
A detailed history of Marshall Wace, LLP transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 597,469 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
597,469
Previous 597,469
-0.0%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ACRV
# of Institutions
46Shares Held
10.7MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY3.01MShares$00.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.68MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA1.65MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY744KShares$00.0% of portfolio